F
FDA
Guest
Baltimore, Maryland, October 14, 2021: Lupin Pharmaceuticals Inc. is voluntarily recalling the below-mentioned batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. As part of Lupin’s ongoing assessment, analysis revealed that certain tested API batches
Baca selengkapnya di : http://www.fda.gov...
Baca selengkapnya di : http://www.fda.gov...